Background: Serum plasmalogens (Pls) have gained interest in several clinical symptoms such as metabolic syndrome/ atherosclerosis or Alzheimer's disease possibly because of their antioxidant properties. We have developed a highly sensitive and simple method to determine plasmenylcholine (PlsCho; choline plasmalogen) and plasmenylethanolamine (PlsEtn; ethanolamine plasmalogen) separately, using a radioactive iodine and high-performance liquid chromatography ( 125 I-HPLC method). The present study reports the improvement and validation of 125 I-HPLC method by introducing a quantitative standard (QS) and online detection with a flow g-counter.
Introduction
Plasmalogens (Pls) are glycerophospholipids containing a vinyl-ether linkage ( -O -CH¼CH -) at the sn-1 position of the glycerol backbone, and are widely distributed in human and animal tissues. 1 Although the physiological roles of Pls are not fully understood, the clinical significances of these phospholipids are recognized in relation to peroxisomal disorders. These diseases are often substantially deficient in Pls, because part of Pls' biosynthetic enzymes are localized in this organelle. 2 Recently, serum (or plasma) Pls have gained interest in several clinical symptoms such as metabolic syndrome/atherosclerosis 3, 4 or Alzheimer's disease 5 other than peroxisomal disorders.
Serum Pls are mainly synthesized in and secreted by liver as a structural component of lipoproteins, 6 and potentially prevent lipoprotein oxidation relevant to atherosclerosis, probably due to the radical scavenging ability of the vinyl-ether double bond. 7, 8 Thus serum (or plasma) Pls are considered as potentially useful biomarkers such as oxidative stress markers. Therefore, a simple and reliable method for the quantification of serum (or plasma) Pls is required for a routine diagnostic test.
The analytical methods for Pls have been developed principally based on the acid labile property of the vinyl-ether linkage of Pls, which leads to the sequential decomposition into fatty aldehydes and 1-lysophospholipids. The resultant fatty aldehydes are usually measured as dimethyl acetal derivatives using gas chromatography/mass spectrometry (GC/MS), 9 and 1-lysophospholipids are measured by two-dimensional thin-layer chromatography (TLC). 10 However, these methods are laborious and insufficient to accurately quantify Pls in a small amount of the serum (or plasma). More recently, liquid chromatography/mass spectrometry (LC/MS) has been applied to the analysis of Pls at the molecular species levels. 11 LC/MS analysis is a powerful method to provide substantial useful information, but the excess data are unlikely to be suitable for a routine diagnostic test, except for specific diagnostic molecular species for particular disorders such as Alzheimer's disease. 5 Our method has been developed based on the binding specificity of iodine to Pls. Although iodine molecule (I 2 ) is well known to reversibly bind to the double bonds of unsaturated lipids, the principle of our method differs from it, and is based on the covalent binding of an iodine atom (I) to Pls. Triiodide (1-) ion (I 3   2 ), which is a reactive iodine molecular form, reacts with a vinyl-ether double bond of Pls in methanol solution specifically and quantitatively. Although the precise reaction mechanism has still remained obscure, we speculate based on the result of MS analysis of the iodine-binding Pls, that an activated iodine molecule (I 2 ) attacks on the double bond of the vinyl-ether moiety of Pls, and a single iodine atom (I) covalently binds to the double bond. On the other hand, other activated halogen species such as hypochlorous acid or hypobromous acid also preferentially react with Pls, but their halogenated products rapidly decompose into chloro-or bromine-fatty aldehydes and 1-lysophospholipids. 12 The difference in the reaction products between iodine and other halogen species may be derived from the size of the binding atom; iodine atom may induce the steric hindrance, and contribute to the structural stability of iodine-binding Pls.
Pls assay based on this principle has already been established. 13 Quantification of Pls is carried out by measuring the decrease in the absorbance at 355-360 nm, which reflects the extent of eliminated triiodide (1-) ion (I 3 2 ) due to the reaction with a vinyl-ether double bond of Pls. We confirmed that the reaction molar ratio of I 3 2 to vinyl-ether bond is exactly 1:1, using several chemical compounds possessing a vinyl-ether bond as well as Pls. 14 However, the 'cold' iodine method has some problems of low detectable Pls concentrations and interfering substances in the extracted lipid samples from biomaterials like serum. The 125 I-HPLC (radioactive iodine and high-performance liquid chromatography) method permitted the highly sensitive and accurate determination of serum (or plasma) Pls by using a radioactive iodine ( 125 I) and removing interfering substances with HPLC. The primary advantage of this method enabled measurement of choline (PlsCho) and ethanolamine plasmalogens (PlsEtn) separately. 14 In the current study, the 125 I-HPLC method has been markedly improved by introducing a quantitative standard (QS) and online detection with flow g-counter. 1-Alkenyl 2,3-cyclic glycerophosphate was decided as a QS in view of both the same quantitative property of Pls and the proper retention time in the HPLC elution profile. Unfortunately, 1-alkenyl 2,3-cyclic glycerophosphate is poorly recovered in the lipid extraction from the serum (or plasma) when it is added in the serum as an internal standard. Therefore, 1-alkenyl 2,3-cyclic glycerophosphate was added following lipid extraction for the purpose of correcting the efficacies of the treatment process subsequent to lipid extraction and measurement. Next, before introducing a flow g-counter into the HPLC system, the radioactivity of iodine-binding Pls had been measured by collecting HPLC elution fractions. Online detection with a flow g-counter permitted a more precise and safe measurement of Pls-related radioactivity. The improved method has been fully validated in terms of selectivity, sensitivity, linearity, precision, accuracy, and has applied to the determination of human serum Pls.
Materials and methods

Materials and chemicals
Natural plasmalogens: plasmenylcholine from bovine heart (PlsCho), plasmenylethanolamine from bovine brain (PlsEtn) and l-a-lyso plasmenylcholine from bovine heart (LyPlsCho) were purchased from Doosan Serdary Research Laboratories (Toronto, Canada). Synthetic 18:0p/18:1-and 18:0p/22:6-PlsCho and PlsEtn ('p' indicates the carbon chain of sn-1 in plasmalogen with a vinyl-ether linkage) were obtained from Avanti Polar Lipids Inc (Alabaster, AL, USA). Other phospholipids were from Sigma-Aldrich Co (St Louis, MO, USA). Radioactive iodine (Na 125 I, 37 MBq/10 mL) was purchased from PerkinElmer Life and Analytical Sciences (Boston, MA, USA). Other chemicals were of the highest purity available from commercial sources.
Human serum was obtained from 120 healthy subjects (age-matched each 60 male and female) and 60 elderly subjects participating in a routine health examination. Serum was also provided by the elderly with dementia or artery stenoses. Written informed consent was obtained from all participants, and the studies were approved by several ethics committees. Serum was separated by centrifugation at 1500g for 10 min of blood collected on ethylenediaminetetraacetic acid, which was immediately frozen at 2808C until use.
'Cold' iodine method for determination of plasmalogens
The concentrations of QS and Pls standards were determined by the 'cold' iodine method 13 with slight modifications. Lipid samples were dissolved in alkali solution ( pH 10.0) because of insufficient solubility of PlsEtn in neutral solution. Lipid samples (100 mL) were mixed with 0.6 mmol/L I-3% KI-50 mmol/L glycine/NaOH ( pH 10.0, 100 mL), and placed in a dark room for 15 -30 min at room temperature. After addition of 2.2 mL ethanol to the mixture, the absorbance of the mixture was measured with a spectrophotometer (V-530; Jasco Co Ltd, Tokyo, Japan) at wavelength 355 -360 nm. A decrease in the absorbance of Pls samples compared with that of blank samples accurately reflects the amounts of Pls because of the equivalent reaction molar ratio of I 3 2 to vinyl-ether double bond of Pls.
Preparation of 1-alkenyl 2,3-cyclic glycerophosphate as QS
Five milligrams LyPlsCho from bovine heart was dispersed in equivalent volume (each 1.5 mL) of diethyl ether and sodium acetate buffer (100 mmol/L, pH 5.6) containing 10 U phospholipase D from Actinomadura sp. (Meito Sangyo Co Ltd, Nagoya, Japan) and 40 mmol/L CaCl 2 , and the mixture was stirred during incubation at 408C for 3-6 h, according to the procedure as described in the literature 15 , and the spots were detected with a primuline reagent. Subsequent to evaporation of diethyl ether in the reaction mixture by blowing N 2 gas, the residual solvent was vigorously mixed with diethyl ether (1.2 mL) and ethanol (3.6 mL) for 10 min, followed by mixing intensely with additional 2 mol/L NaCl (9.0 mL) and diethyl ether (4.8 mL) for five minutes. Ether fraction including 1-alkenyl 2,3-cyclic glycerophosphate (upper layer) was collected by centrifugation at 1000g for 15 min, and recovered by additional diethyl ether (3.0 mL) and centrifugation again. The collective ether fractions were evaporated under N 2 gas, re-dissolved in CHCl 3 and stored at 2208C until use ( Figure 1 ). The recovery rate of 1-alkenyl 2,3-cyclic glycerophosphate corresponded to approximately 70% of LyPlsCho, added in the reaction mixture. The purity of 1-alkenyl 2,3-cyclic glycerophosphate in the preparation was usually .90% without further purification, which is estimated by the 125 I-HPLC method. The concentration was adjusted to 100 mmol/L in CHCl 3 /MeOH (9:1) for a stock solution.
Sample preparation from human serum
Human serum (0.2 mL) was intensely mixed with diethyl ether (0.2 mL) and ethanol (0.6 mL) in a glass tube for 10 min. Following vigorous stirring of the mixture with additional ethanol (1.0 mL) and distilled water (1.6 mL), the ether fraction (upper layer) was collected by centrifugation (4000g, for 30 min, at 208C). To completely recover Pls, the lower layer was intensely mixed with additional diethyl ether (1.0 mL), and the ether fraction was collected again. By this procedure, almost 100% Pls was recovered from human serum. Aliquots of 1-alkenyl 2,3-cyclic glycerophosphate (100 mmol/L) were added as the QS accurately with a microsyringe to the collected ether solution. Following evaporation to dryness with N 2 gas stream, samples were re-dissolved in methanol (100 mL) and filtered through a 0.45-mm filter (Chromato disk 4N; Kurabo Industries Ltd, Osaka, Japan) for LC analysis. For the preparation of quality control samples, both PlsCho and PlsEtn standards (each 100 mmol/L) were re-dissolved in methanol with the QS (100 mmol/L) just before analysis.
125
I-HPLC
Lipid samples (30 mL) were mixed with 125 I reagent (5 mL), prepared as described previously, 14 in borosilicate glass, vial-attached, rubber covers for an autosample injector, and stood overnight at 48C. It was confirmed that the reaction was completed till 12 h, and that the iodine-binding products were satisfactorily stable at least till 48 h at 48C. Liquid chromatography separation was performed using a 
Results and discussion
Extraction of Pls from human serum Pls extraction efficiencies from human serum (250 mL) were compared in different extraction methods as follows: (1) Bligh and Dyer; 16 (2) serum lyophilization followed by extraction with chloroform/methanol (1:2, by vol.); (3) extraction with either hexane/ethanol (3:2, by vol.); or (4) ethanol/diethyl ether (1:2, by vol.). Aliquots of the extracted lipids were subjected to solid phase column (100 mg, Varian BondElut NH 2 ; GL Sciences Inc, Tokyo, Japan) to isolate phospholipids. The measurements by 125 I-HPLC method show that the extraction with ethanol/ether is most effective in recovering Pls from the serum. The hexane/ethanol extraction was also an efficient method, but the propensity for lower recovery of PlsCho compared with that of PlsEtn was observed (Table 1 ). There were no significant differences in the measurements between with and without column treatment. Therefore, ethanol/ether extraction without column treatment was adapted in this method thereafter.
LyPlsCho ( Figure 2 . Subsequent to the elution of non-binding iodine (void fraction), the QS, PlsCho and PlsEtn were eluted as separate single peaks in the order. These radioactive peak fractions were collected in test tubes, and their radiocounts (cpm) were measured with a well type g-counter (ARC-380CL; Aloka Co Ltd, Tokyo, Japan). The relationship between the radioactive peak area detected with a flow g-counter (mV) and the radiocounts (cpm) measured with a well type g-counter were examined for QS and Pls standards. The linear relationships, having almost the same slope, between the peak areas and radio counts were obtained in all the examined analytes (Figure 3 ). This indicates that the detection with a flow g-counter is available to measure radioactivity regardless of peak shape and elution time on LC. The plots of the amounts of binding-iodine, which were estimated based on the measured radioactivity, against the actual amounts of Pls or QS show that the binding ratio of iodine to Pls or QS is exactly 1:2, as described previously. 14 This apparent binding ratio seems to be due to a radioisotopic effect. In the case of making a pair of a radiolabelling atom with a non-radiolabelling atom, the radiolabelling effect would reduce by half when only either atom in a pair combines to Pls. Therefore, the actual binding ratio of iodine (I) to Pls or QS should be regarded as 1:1, which is consistent with the result of MS analysis of iodine-binding Pls (data not shown).
Quantification of Pls by 125 I-HPLC method
Quantification was carried out as follows: (1) convert the peak area (mV) on LC detected with a flow g-counter into the radiocounts (cpm) by using the equation to adjust for correlation between them; (2) calculate the amounts of iodine (I) bound to Pls from the radio counts based on the radioactivity of 125 I, which is determined considering the decay rate of 125 I (T1/2, 60.14 d); (3) estimate the amount of Pls two times as that of binding iodine because of the apparent binding ratio of iodine to Pls (1:2); and (4) correct the amount of Pls with the measurement efficiency, which is calculated from simultaneous measurement of the QS. Conveniently, it is possible to quantify Pls from the relative ratio of peak area to that of the QS.
Validation
The following validation parameters have been evaluated: selectivity, linearity, limit of detection (LOD), lower limit of quantification (LLOQ), precision, accuracy and recovery. Selectivity of the method was evaluated by the analysis of blank lipid samples: HCl-treated lipids extracted from human serum or diacyl counterparts such as phosphatidylcholine and phosphatidylethanolamine. None of these samples gave any peaks or chromatographic interference (data not shown). Linearity was established over the concentration range 5 -300 mmol/L for PlsCho and PlsEtn as well as the QS, and the regression coefficients were all .0.99. The LOD was defined as the lower concentration with a signal-to-noise ratio for all peaks of at least 3, and was empirically determined as 5 mmol/L each for PlsCho and PlsEtn. The LLOQ was defined as the lowest concentration that could be quantified with acceptable precision (coefficient of variation percentage, CV%) +20% and accuracy (mean relative error percentage, MRE%) ,20%. The LLOQ for PlsCho and PlsEtn were 6 mmol/L (CV 5.5%, MRE 9.8%) and 12 mmol/L (CV 5.3%, MRE 4.8%), respectively. Precision and accuracy were evaluated at three different concentrations for PlsCho and PlsEtn. Intraday precision and accuracy were assessed by analysing five replicates at each concentration in the same run. Interday precision and accuracy were tested by analysing other three concentrations on five different days. Precision was expressed in terms of imprecision by the calculation of the CV% of the measured values, which was required to be +15%, except for the LLOQ for which values +20% were accepted. The values of intra-and interday CV% of QS were 1.6% and 2.8%, respectively, those of PlsCho were 2.7 -6.0% and 2.8 -4.4%, respectively, and those of PlsEtn were 1.1 -2.3% and 2.7 -4.6%, respectively ( Table 2 ). Inaccuracy was evaluated by determining the MRE, which is the percentage deviation from the accepted reference value. The values of intra-and interday MRE% of QS were 2.0% and 2.4%, respectively, those of PlsCho were 2.3 -7.4% and 2.9-11.6%, respectively, and those of PlsEtn were 2.3 -5.3% and 4.0 -12.5%, respectively ( Table 2 ). The accuracy and reliability were satisfactory. Recovery rates of Pls from the serum were tested by adding three different concentrations of PlsCho and PlsEtn standards to the control serum (150 mL).
The recovery rates were .94% for PlsCho and PlsEtn, but they declined to .60% when Pl concentrations added in the serum were less than 20 mmol/L. We conclude that the improved 125 I-HPLC method is fully validated for a routine diagnostic test of human serum (or plasma) Pls. Binding-I, nmol Pls, nmol Figure 3 Linear regression analysis between peak areas on liquid chromatography (LC) and radio counts, and the analysis between the amounts of binding-iodine and plasmalogens (Pls) or quantitative standard (QS). Peak areas of each Pls standards and QS were measured by LC with a flow g-counter, and the radio counts of the collected fractions corresponding to peak areas were determined with well-type g-counter, and the amounts of binding-iodine were calculated based on the radioactivity of 125 
Stability of Pls and QS during storage
Pls standards and QS were assessed for the stability during storage in several stock solutions at different temperatures by examining the residual%. It was shown that Pls are labile in methanol regardless of thermal conditions (4, 220, 2808C), whereas they are completely stable in chloroform or diethyl ether as a stock solvent at 2208C till eight weeks' examined period. On examination of the freezethawing cycle, PlsEtn was shown to be more labile than
PlsCho (Figure 4 ). QS was more stable than Pls in chloroform, and confirmed to be fully stable for more than three months at 2208C (data not shown). Pls in the serum were stable at least for three months during storage at 2808C, but thereafter they gradually decomposed. Lipid samples extracted from the serum were also sufficiently stable in chloroform as well as Pls standards. These results suggest that it is desirable to use or measure Pls standards, QS, and extracted lipids in chloroform or serum samples stored at 2208C or 2808C within three months.
Quantification of human serum Pls
Human serum was obtained from 120 healthy subjects, 60 elderly subjects and elderly with dementia (CDR 0.5 ) or significant artery stenoses. Their serum Pls concentrations were quantified by 125 I-HPLC method (Tables 3 and 4 ). The measurements were nearly identical to our previous results 3, 4, 14 and other report. 17 Interestingly, there was a statistically significant defference in PlsCho concentration between male and female of healthy subjects, in spite of no significant differences in PlsEtn and total phospholipid (PL) concentrations between them (Table 3 ). It is known that PlsCho is exclusively biosynthesized from PlsEtn; hence some sex hormones may influence the conversion process. 18 Serum PlsCho concentrations, PlsCho/PlsEtn ratio and PL of elderly with artery stenoses were significantly reduced compared with other elderly groups. On the other hand, PlsEtn/PL% as well as total Pls/PL% of elderly with dementia was significantly decreased compared with any other groups (Table 4 ). These results demonstrate that the determination of serum Pls with this method is available to diagnose clinical symptoms.
We conclude that the improved 125 I-HPLC method is fully validated, and is useful as a continious autoanalytical system for a routine diagnostic test of human serum (or plasma) Pls. 
